[SaNOtize in The ECRAID] ECRAID-Prime and SaNOtize to begin trial on antiviral nasal spray
ECRAID-Prime and SaNOtize Research and Development Corp. have signed a collaboration agreement to begin the first study of SaNOtize’s antiviral nitric oxide nasal spray (NONSTM), using Europe’s adaptive platform trial in primary care. Read more...
Read More